Part 7/15:
Sanders voices concern about the dominance of pharmaceutical and insurance industries, which spend billions annually on lobbying and advertising to maintain high drug prices and oppose reform. For example, drug companies spent $131 million in just one state to defeat a ballot measure aimed at controlling prescription prices.
He advocates for expanding Medicare negotiation powers, ending skyrocketing drug costs, and combating the influence of corporate lobbying—changes he views as essential to make healthcare truly accessible and affordable.